SCHEMBL7654193

SCHEMBL7654193

CCOC(=O)N=C(N)c1ccc(NC(=O)c2ccccc2-c2ccccc2C(=O)NO)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.50
RAB9A P51151 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
NPC1 O15118 4/20 0.50
ALDH1A1 P00352 4/20 0.50
GAA P10253 3/20 0.50
KDM4E B2RXH2 2/20 0.45
KLK1 P06870 2/20 0.42
KLK5 Q9Y337 2/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
PLAU P00749 2/20 0.42
PLAT P00750 2/20 0.42
F2 P00734 2/20 0.41
F10 P00742 2/20 0.41
PLG P00747 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41
F7 P08709 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7658461 0.91 SMN1; SMN2 (0.56) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7661471 0.91 CYP3A4 (0.53) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7657150 0.88 CYP3A4 (0.49) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7663254 0.86 ALDH1A1 (0.47) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7656002 0.86 RAB9A (0.45) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7662346 0.84 SMN1; SMN2 (0.50) SMN1; SMN2RAB9AMEN1KMT2ANPC1
SCHEMBL7688990 0.81 F3 (0.63) F2F10PLGPRSS1PRSS2
SCHEMBL7657788 0.80 NPC1 (0.53) RAB9AMEN1KMT2ANPC1ALDH1A1
Hydrochloric Acid SCHEMBL7662470 0.79 NPC1 (0.52) RAB9AMEN1KMT2ANPC1ALDH1A1
SCHEMBL7659362 0.79 CYP2C9 (0.51) MEN1KMT2AALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US claimed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP claimed
US-6358960-B1 FOR THERAPY OF INTRAVASCULAR COAGULATION, CORONARY THROMBOSIS, CEREBRAL INFARCTION, CEREBRAL EMBOLISM, TRANSIENT ISCHEMIC ATTACK, CEREBROVASCULAR DISORDERS, PULMONARY VASCULAR DISEASES, DEEP VENOUS THROMBOSIS, ETC. ONO PHARMACEUTICAL CO., LTD. (JP) 2002-03-19 US disclosed
EP-1078917-A1 AMIDINO DERIVATIVES AND DRUGS CONTAINING THE SAME AS THE ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 2001-02-28 EP disclosed